[1] Fuchs, B.; Süß, R.; Nimptsch, A.; Schiller, J. MALDI-TOF-MS Directly Combined with TLC: A Review of the Current State. Chromatographia 2009, 69, 95–105.
[2] Zhao, Q.; Zhao, Y.; Wang, K. Antinociceptive and free radical scavenging activities of alkaloids isolated from Lindera angustifolia Chen. J. Ethnopharmacol. 2006, 106, 408–413.
[3] Wang, C.; Dai, Y.; Yang, J.; Chou, G.; Wang, C.; Wang, Z. Treatment with total alkaloids from Radix Linderae reduces inflammation and joint destruction in type II collagen-induced model for rheumatoid arthritis. J. Ethnopharmacol. 2007, 111, 322–328.
[4] Gan, L. S.; Zheng, Y. L.; Mo, J. X.; Liu, X.; Li, X. H.; Zhou, C. X. Sesquiterpene Lactones from the Root Tubers of Lindera aggregata. J. Nat. Prod. 2009, 72, 1497–1501.
[5] Chen, C. J.; Liu, X.; Chiou, J. S.; Liang, W. H.; Li, T, M.; Fuu-Jen, T.; Ko, C. H.; Lin, T. H.; Liao, C. C.; Huang, S. M.; Liang, W. M.; Lin, Y. J. Effects of Chinese herbal medicines on dementia risk in patients with sleep disorders in Taiwan. J. Ethnopharmacol. 2020, 264, 113267.
[6] Cheng, X. L.; Ma, S. C.; Wei, F.; Wang, G. L.; Xiao, X. Y.; Lin, R. C. A new sesquiterpene isolated from Lindera aggregata (SIMS) KOSTERM. Chem. Pharm. Bull. 2007, 55, 1390–1392.
[7] Sumioka, H.; Harinantenaina, L.; Matsunami, K.; Otsuka, H.; Kawahata, M.; Yamaguchi, K. Linderolides A-F, eudesmane-type sesquiterpene lactones and linderoline, a germacrane-type sesquiterpene from the roots of Lindera strychnifolia and their inhibitory activity on NO production in RAW 264.7 cells in vitro. Phytochemistry 2011, 72, 2165–2171.
[8] Yang, C. P.; Huang, G. J.; Huang, H. C.; Chen, Y. C.; Chang, C. I.; Wang, S. Y.; Chen, I. S.; Tseng, Y. H.; Chien, S. C.; Kuo, Y. H. A New Butanolide Compound from the Aerial Part of Lindera akoensis with Anti-inflammatory Activity. Molecules 2012, 17, 6585–6592.
[9] Kozuka, M.; Yoshikawa, M.; Sawada, T. Alkaloids from Lindera strychnifolia. J. Nat. Prod. 1984, 47, 1063.
[10] Chen, K. S.; Wu, Y. C.; Teng, C. M.; Ko, F. N.; Wu, T. S. Bioactive Alkaloids from Illigera luzonensis. J. Nat. Prod. 1997, 60, 645–647.
[11] Chang, Y. C.; Chang, F. R.; Wu, Y. C. The Constituents of Lindera glauca. J. Chin. Chem. Soc. 2000, 47, 373–380.
[12] Hwang, E. I.; Lee, Y. M.; Lee, S. M.; Yeo, W. H.; Moon, J. S.; Kang, T. H.; Park, K. D.; Kim, S. U. Inhibition of Chitin Synthase 2 and Antifungal Activity of Lignans from the Stem Bark of Lindera erythrocarpa. Planta Med. 2007, 73, 679–682.
[13] Kim, K. H.; Moon, E.; Ha, S. K.; Suh, W. S.; Kim, H. K.; Kim, S. Y.; Choi, S. U.; Lee, K. R. Bioactive Lignan Constituents from the Twigs of Lindera glauca. Bioactive Lignan Constituents from the Twigs of Lindera glauca. Chem. Pharm. Bull. 2014, 62, 1136–1140.
[14] Cao, Y.; Xuan, B. F.; Peng, B.; Li, C.; Chai, X. Y.; Tu, P. F. The genus Lindera: a source of structurally diverse molecules having pharmacological significance. Phytochem. Rev. 2016, 15, 869–906. |